NO to Breast: When, Why and Why Not?
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
451-462
Author(s):
Shehla Pervin, Gautam Chaudhuri and Rajan Singh
Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
Journal:
Current Drug Targets
Volume:
10
Page:
923-936
Author(s):
Antonio Gualberto and Michael Pollak
Biomarkers, Critical Disease Pathways, Drug Targets, and Alternative Medicine in Male Breast Cancer
Journal:
Current Drug Targets
Volume:
10
Page:
1-8
Author(s):
Debmalya Barh
Environmental Chemicals and Breast Cancer Risk – A Structural Chemistry Perspective
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
2680-2701
Author(s):
Jamie Weyandt, Rachel E. Ellsworth, Jeffrey A. Hooke, Craig D. Shriver and Darrell L. Ellsworth
Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Journal:
Current Pharmacogenomics
Volume:
5
Page:
280-291
Author(s):
Bernard Friedenson
Environmental Exposure, and Other Behavioral Risk Factors in Breast Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
2
Page:
3-21
Author(s):
Joanna Kruk and Hassan Y. Aboul-Enein
Aromatase Inhibitors: A New Paradigm in Breast Cancer Treatment
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
523-534
Author(s):
J. Narashimamurthy, A. Raghu Ram Rao and G. Narahari Sastry
Breast Cancer: Biological Characteristics in Postmenopausal Type 2 Diabetic Women. Identification of Therapeutic Targets
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
3
Page:
205-209
Author(s):
E. Guastamacchia, F. Resta, A. Mangia, F. Schittulli, A. Ciampolillo, V. Triggiani, B. Licchelli, A. Paradiso, C. Sabba and E. Tafaro
Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition
Journal:
Current Genomics
Volume:
3
Page:
389-412
Author(s):
M. K. Sauer